Comparison of health insurance claims and patient interviews in assessing drug use: Data from the Three-City (3C) Study

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 4, 2009, Pages 310-319

  Noize, Pernelle ^a,b,c   Bazin, Fabienne ^a,b   Dufouil, Carole ^d,e   Lechevallier Michel, Nathalie ^b   Ancelin, Marie Laure ^d   Dartigues, Jean François ^b,c,d   Tzourio, Christophe ^d,e   Moore, Nicholas ^a,b,c   Fourrier Réglat, Annie ^a,b,c  

^a INSERM U657   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Agreement; Interview; Medicines; Pharmacoepidemiology; Reimbursement databases; Validity (epidemiology)

Indexed keywords

AGENTS AFFECTING METABOLISM; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIGOUT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ANTIRHEUMATIC AGENT; BENZODIAZEPINE DERIVATIVE; CARDIAC GLYCOSIDE; CARDIOVASCULAR AGENT; CHONDROITIN SULFATE; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; LAXATIVE; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PSYCHOSTIMULANT AGENT; RESPIRATORY TRACT AGENT; UNINDEXED DRUG; VASODILATOR AGENT; VITAMIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DRUG USE; DRUG UTILIZATION; FEMALE; FRANCE; GOLD STANDARD; HEART DISEASE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; NEUROPSYCHIATRY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REIMBURSEMENT; RHEUMATIC DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; DATA BASE; HEALTH INSURANCE; METHODOLOGY; MULTICENTER STUDY; PROSPECTIVE STUDY; REPRODUCIBILITY; SELF MEDICATION; STATISTICS; TIME;

AGED; AGED, 80 AND OVER; DATABASES AS TOPIC; DRUG UTILIZATION REVIEW; FEMALE; FRANCE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; INSURANCE, PHARMACEUTICAL SERVICES; INTERVIEWS AS TOPIC; MALE; PHARMACOEPIDEMIOLOGY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SELF MEDICATION; TIME FACTORS;

EID: 65449176066     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1717     Document Type: Article

References (24)

1. West SL, Strom BL, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In Pharmacoepidemiology, Strom BL (ed.). John Wiley & Sons: Chichester, 2005; 709-765.
2. Horwitz RI, Feinstein AR, Stremlau JR. Alternative data sources and discrepant results in case-control studies of estrogens and endometrial cancer. Am J Epidemiol 1980; 111: 389-394.
3. Moore N, Masson H, Noblet C, Joannidès R. What medicines do patients really take? A comparison of free form vs. oriented questionnaires. Post Mark Surveill 1993; 7: 355-362.
4. Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 1991; 13: 91-96.
5. West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995; 142: 1103-1112.
6. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990; 131: 815-825.
7. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000; 53: 273-277.
8. Metlay JP, Hardy C, Strom BL. Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics. Pharmacoepidemiol Drug Saf 2003; 12: 9-15. DOI: 10.1002/pds.772
9. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116: 114-122.
10. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 1989; 129: 233-248.
11. Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Bégaud B. Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin Pharmacol Ther 2001; 69: 445-450. DOI: 10.1067/mcp.2001.116147
12. Depont F, Fourrier A, Merlière Y, et al. The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf 2007; 16: 571-580. DOI: 10.1002/pds.1348
13. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy. Ann Pharmacother 1994; 28: 99-104.
14. McKenzie DA, Semradek J, McFarland BH, Mulloolr JP, Mc Camant LE. The validity of Medicaid pharmacy claims for estimating drug use among elderly nursing home residents: The Oregon experience. J Clin Epidemiol 2000; 53: 1248-1257.
15. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991; 39: 1079-1084.
16. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. For the PREVEND Study Group. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379-384. DOI: 10.1002/pds.722
17. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997; 50: 619-625.
18. The 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003; 22: 316-325. DOI: 10.1159/000072920
19. World Health Organization. Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. World Health Organization, Oslo; 2000.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
21. Weiss NS. Studies of diagnostic and screening tests. In Modern Epidemiology, Rothman KJ, Greenland S (eds). Lippincott-Raven: Philadelphia, 1998; 520-524.
22. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci 1999; 21: 217-220.
23. Sjahid SI, Van der Linden PD, Stricker BH. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdamelderly study. Br J Clin Pharmacol 1998; 45: 591-595.
24. Van Staa TP, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol 1994; 47: 183-189.